ImmunoGen
Focusing on core therapeutic areas such as immunology, oncology, neuroscience, eye care, aesthetics, and other areas of unmet need. Learn more
Launch date
Employees
Market cap
CAD11.9b
Enterprise valuation
CAD11.2b (Public information from Feb 2024)
Share price
$31.23 IMGN
Waltham Massachusetts (HQ)
Authorizing premium user...